Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Frontiers Media SA full text link Frontiers Media SA Free PMC article
Full text links

Actions

Share

Editorial
.2020 Oct 8:11:603900.
doi: 10.3389/fimmu.2020.603900. eCollection 2020.

Editorial: Mycobacterial Glycolipids-Role in Immunomodulation and Targets for Vaccine Development

Affiliations
Editorial

Editorial: Mycobacterial Glycolipids-Role in Immunomodulation and Targets for Vaccine Development

Gunilla Källenius et al. Front Immunol..
No abstract available

Keywords: Mycobacterium leprae; Mycobacterium tuberculosis; Mycobacterium ulcerans; glycolipid; immunomodulation; lipoarabinomannan; vaccine.

PubMed Disclaimer

Comment on

  • Editorial on the Research Topic Mycobacterial Glycolipids—Role in Immunomodulation and Targets for Vaccine Development

Similar articles

See all similar articles

Cited by

References

    1. WHO. World Health Organization Global Tuberculosis Report 2019. (World Health Organization; ) (2019). Available at:https://www.who.int/tb/publications/global_report/tb19_Exec_Sum_12Nov201....
    1. WHO. World Health Organization Global strategy and targets for tuberculosis prevention, care and control after 2015. (World Health Organization; ) (2014). Available at:https://www.who.int/tb/post_2015_tb_presentation.pdf.
    1. Lienhardt C, Lonnroth K, Menzies D, Balasegaram M, Chakaya J, Cobelens F, et al. Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions. PloS Med (2016) 13:e1001965. 10.1371/journal.pmed.1001965 - DOI - PMC - PubMed
    1. Andersen P, Scriba TJ. Moving tuberculosis vaccines from theory to practice. Nat Rev Immunol (2019) 19:550–62. 10.1038/s41577-019-0174-z - DOI - PubMed
    1. Correia-Neves M, Froberg G, Korshun L, Viegas S, Vaz P, Ramanlal N, et al. Biomarkers for tuberculosis: the case for lipoarabinomannan. ERJ Open Res (2019) 5:00115–2018. 10.1183/23120541.00115-2018 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full text links
Frontiers Media SA full text link Frontiers Media SA Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp